Skip to main content

Table 1 Subject enrolment and measurements

From: HPV types, HIV and invasive cervical carcinoma risk in Kampala, Uganda: a case-control study

 

Cases

%

Controls

%

Women invited to participate

484

100.0

385

100.0

Declined to participate

66

13.6

22

5.7

Incomplete questionnaires

41

8.5

44

11.4

Diagnosis not confirmeda

61

12.6

5

1.3

Total preliminarily recruitedb

316

100.0

314

100.0

Samples for HPV testingb

239c

75.6

309

98.4

Samples for HIV testingb

281

88.9

308

98.1

Combined HIV and HPV samplesb

222

70.3

303

96.5

  1. Invasive cervical carcinoma study in Kampala, Uganda
  2. a Diagnosis of invasive cervical carcinoma not confirmed by histology for cases; control women found with abnormal cervical smears (cervical intraepithelial neoplasia, not invasive cervical carcinoma).
  3. b Percent based on total recruited.
  4. c In addition to these 239, 16 cases were beta-globin-negative and therefore excluded from all analyses.
  5. Abbreviations: HPV: human papillomavirus.